CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts & leukoencephalopathy)

From Aaushi
Jump to navigation Jump to search

Epidemiology

  • affects relatively young adults of both sexes

Pathology

Genetics

Clinical manifestations

Radiology

Complications

Differential diagnosis

  • CARASIL
    • symptom onset in CARASIL ~ 10-15 years earlier than in CADASIL
    • memory dysfunction appears to be more severe than CADASIL

Management

More general terms

Additional terms

References

  1. Joutel et al. Nature 383:707-10 1996 Tournier-Lasserve et al. Nature Genetics 3:256-9 1993
  2. 2.0 2.1 Kalaria RN, Viitanen M, Kalimo H, Dichgans M, Tabira T; The CADASIL Group of Vas-Cog. The pathogenesis of CADASIL: an update. J Neurol Sci. 2004 Nov 15;226(1-2):35-9. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15537516
  3. 3.0 3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 Toro J, Duque A, Reyes S, Patino J. Case Challenge: A Man with Migraine and Behavioral Changes. NEJM Journal Watch. Sept 12, 2017 Case Conclusion: A Man with Migraine and Behavioral Changes. NEJM Journal Watch. Sept 26, 2017 Massachusetts Medical Society (subscription needed) http://www.jwatch.org
  4. Di Donato I, Bianchi S, De Stefano N et al Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) as a model of small vessel disease: update on clinical, diagnostic, and management aspects. BMC Med. 2017 Feb 24;15(1):41. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/28231783 Free PMC Article

Patient information

CADASIL patient information

Database